product Image
[DT] DiaStar™ Taq DNA Polymerase (Amplification)
Model Name
-
Series
Research Reagents (PCR)
Data
메뉴얼-솔젠트-DT16-R500,_R25h,_R50h_DiaStar™_Taq_DNA_Polymerase
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125138
Product Name
[DT] DiaStar™ Taq DNA Polymerase (Amplification)
Model Name
-
Size
-
Weight
-
Product Details

[DT] DiaStar™ Taq DNA Polymerase

Hot start PCR enzyme for high sensitivity & high efficiency

Antibody-mediated Hot start enzyme

High sensitivity & productivity

Amplicon size : ~ 5 kb


DiaStar™ Taq polymerase is antibody mediated HotStart DNA polymerase which has high sensitivity and high specificity. It is effective in inhibition of dimer formation and amplification of Low-copy DNA. It is recommended to use it when amplifying 5 Kb or less.




Specification

SourceThermus aquaticus
(Recombinant)
Amplicon size~ 5 kb
Hot start activityYes (Antibody-mediated)
5’→ 3’ exonuclease activityYes3’A or Blunt ends3’A
3’→ 5’ exonuclease activit yNoError rate12-13 bp error / 10⁶ bp





Application

Amplification of low-copy DNA targets, High throughput hot start PCR, Highly specific amplification of genomic and cDNA tar gets, TA cloning




Format

FormatProduct ImageContentsStorage & Expiry Date
Standard

DiaStar™ Taq DNA Polymerase (5 U/㎕)
10X Taq Reaction Buffer (25 mM MgCl₂mixed)
10 mM dNTP Mix
5X Band Doctor™
2 years 3 months (In case of Store at -20 ℃ ± 5 ℃)




Ordering information

FormatCat. No.ProductSizePrice(won)
StandardDT16-R500DiaStar™ Taq DNA Polymerase500 U
(400 reaction)
-
DT16-R25hDiaStar™ Taq DNA Polymerase2,500 U
(500 U x 5 ea)
-
DT16-R50hDiaStar™ Taq DNA Polymerase5,000 U
(500 U x 10 ea)
-
Single itemDT22-B50hDiaStar™ 10X Taq Reaction Buffer1 ㎖ x 5 ea
(1,000 reaction)
-



More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry